Mechanical control of breast cancer malignancy by promotion of mevalonate pathway enzyme synthesis
Matrix Biology · 2025-09 · 140 · 1-15
DOI: 10.1016/j.matbio.2025.05.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Matrix Biology, 2025-09. Verfasst von Sara Göransson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden. Hauptthemen laut MEDLINE: Mevalonic Acid, Breast Neoplasms, Mechanotransduction, Cellular, Hydroxymethylglutaryl-CoA Synthase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Cancer Society, Radiumhemmets forskningsfonder.
Abstract (Originalsprache)
In breast cancer, mechanotransduction from stiffened extracellular matrix (ECM) drives proliferation and invasion. Here, we use a model of matrix stiffening mimicking progression of breast ductal carcinoma in situ to invasive ductal carcinoma. Quantitative mass spectrometry identified enrichment of ECM-stiffness upregulated mevalonate pathway enzymes, indicating sterol/isoprenoid metabolism reprogramming. Consistently, the first committed mevalonate pathway enzyme, Hydroxymethylglutaryl-CoA Synthase (HMGCS1), was upregulated in human breast cancer specimens and spatially correlated with cross-linked ECM. ECM-stiffness promoted HMGCS1 protein synthesis without corresponding mRNA level alterations, indicating post-transcriptional regulation of mevalonate biosynthesis via microenvironmental mechanical cues to impose rapid metabolic alterations. Moreover, HMGCS1-RNAi blocked the stiffness-driven breast cancer proliferative and invasive phenotype. Mechanistically, mechanotransduction signaling, through integrin and Rac1 to promote HMGCS1 protein expression, drives the breast cancer malignant phenotype. Intriguingly, the Rac1-P29S cancer mutant promoted a malignant phenotype without stiff ECM in a mevalonate-dependent manner. In summary, we define a mechano-responsive pathway controlling mevalonate pathway enzyme synthesis that drives breast cancer malignant behaviors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden.
- Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden.
- International Research Center, A. C. Camargo Cancer Center, Sao Paulo, Brazil.
- Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Solna, Sweden; Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
- Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden. Electronic address: staffan.stromblad@ki.se.
Förderung
- Swedish Research Council
- Swedish Cancer Society
- Radiumhemmets forskningsfonder
- Knut and Alice Wallenberg Foundation
- Karolinska Institutet
- Cancer Research Foundations of Radiumhemmet
Zitieren
APA
Göransson, S., Olofsson, H., Johansson, H. J., Yan, F., Vogiatzakis, C., Liang, S., Bellato, H. M., Masvidal, L., Aksoylu, I., Hartman, J., Hajj, G. N., Larsson, O., Lehtiö, J., & Strömblad, S. (2025). Mechanical control of breast cancer malignancy by promotion of mevalonate pathway enzyme synthesis. Matrix Biology, 140, 1-15. https://doi.org/10.1016/j.matbio.2025.05.005
Vancouver
Göransson S, Olofsson H, Johansson HJ, Yan F, Vogiatzakis C, Liang S, et al. Mechanical control of breast cancer malignancy by promotion of mevalonate pathway enzyme synthesis. Matrix Biology. 2025;140:1-15. doi:10.1016/j.matbio.2025.05.005
BibTeX
@article{Gransson2025,
author = {Göransson, Sara and Olofsson, Helene and Johansson, Henrik J and Yan, Feifei and Vogiatzakis, Christos and Liang, Shuo and Bellato, Hermano Martins and Masvidal, Laia and Aksoylu, Inci and Hartman, Johan and Hajj, Glaucia Nm and Larsson, Ola and Lehtiö, Janne and Strömblad, Staffan},
title = {Mechanical control of breast cancer malignancy by promotion of mevalonate pathway enzyme synthesis},
journal = {Matrix Biology},
year = {2025},
volume = {140},
pages = {1--15},
doi = {10.1016/j.matbio.2025.05.005}
}
EUVIMED